Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/22/1995 | EP0682710A1 Immobilized proteins with specific binding capacities and their use in processes and products |
11/22/1995 | EP0682708A1 Antiviral composition of viral protein trans-dominant variants |
11/22/1995 | EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
11/22/1995 | EP0682706A1 Novel compounds |
11/22/1995 | EP0682705A1 Tnf-alpha muteins and a process for preparing them |
11/22/1995 | EP0682704A1 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
11/22/1995 | EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
11/22/1995 | EP0682701A1 APOLIPOPROTEIN B mRNA EDITING PROTEIN COMPOSITIONS AND METHODS |
11/22/1995 | EP0682699A1 FUNCTIONAL DOMAINS IN $i(FLAVOBACTERIUM OKEANOKOITES) (FOKI) RESTRICTION ENDONUCLEASE |
11/22/1995 | EP0682698A1 Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby |
11/22/1995 | EP0682529A1 Antibody for the treatment of insulin dependent diabetes |
11/22/1995 | EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
11/22/1995 | EP0635028A4 Pulmonary surfactant protein fragments. |
11/22/1995 | EP0485608B1 Method for obtaining polypeptides in a cell-free translation system |
11/22/1995 | EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna |
11/22/1995 | CN1112368A Paper strengthened with solubilized collagen, and method for making the same |
11/22/1995 | CN1112356A Novel attenuated pseudomonas aeruginosa strains |
11/22/1995 | CN1112127A A novel polypeptide of protein p140 and DNAS encoding it |
11/22/1995 | CN1112126A Polyamid-oligonucleotide derivative, preparation and application of same |
11/22/1995 | CN1111946A Protein isolate having an increased level of lsoflavone compounds, and process for producing the same |
11/21/1995 | USRE35097 Gene for diagnosing cancer metastatic potential |
11/21/1995 | US5468845 Antibodies to osteogenic proteins |
11/21/1995 | US5468844 Process for the membrane-filtering of protein solutions |
11/21/1995 | US5468639 With specified amino acid sequence and plasmid comprising the same; vaccine against enteric infections |
11/21/1995 | US5468636 Aphidicides |
11/21/1995 | US5468634 Axl oncogene |
11/21/1995 | US5468624 Polynucleotide with sequyence code and cells |
11/21/1995 | US5468623 Method of converting big endothelin-1 to endothelin-1 with human apolipoprotein B |
11/21/1995 | US5468617 Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor |
11/21/1995 | US5468615 Adding a compound to eukaryotic cell transformed with vector capable of expressing human dopamine receptor, assaying affinity of compound for receptor |
11/21/1995 | US5468613 Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
11/21/1995 | US5468612 Proteins, genetic vectors and cells |
11/21/1995 | US5468611 Method for HLA typing |
11/21/1995 | US5468609 Production of interferon |
11/21/1995 | US5468608 Production of interferon |
11/21/1995 | US5468607 Production of interferon |
11/21/1995 | US5468494 Polypeptides as anticarcinogenic agents |
11/21/1995 | US5468484 Method of prevention of pseudomonas infection |
11/21/1995 | US5468483 Bacillus thuringiensis anti-giardia treatment |
11/21/1995 | US5468481 Glycoside antigen peptides for autoimmune diseases |
11/21/1995 | US5468480 Pharmaceutical composition of purified chymopapain |
11/21/1995 | US5468468 Method for making a monoclonal antibody, monoclonal antibodies to α PD |
11/21/1995 | CA2149703A1 Mucosal administration of pneumococcal antigens |
11/21/1995 | CA2149345A1 Epitopic regions of pneumococcal surface protein a |
11/21/1995 | CA1337596C Varicella-zoster virus as a live recombinant vaccine |
11/19/1995 | CA2149579A1 Process for producing recombinant human serum albumin |
11/19/1995 | CA2149375A1 Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural n-terminal sequence |
11/18/1995 | CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica |
11/16/1995 | WO1995030775A1 High-affinity ligands of insulin receptor antibodies, tachykinin substance p, hiv integrase and hiv-1 reverse transcriptase |
11/16/1995 | WO1995030770A1 Dry prothrombin time assay |
11/16/1995 | WO1995030762A1 Sv-40 derived dna constructs comprising exogenous dna sequences |
11/16/1995 | WO1995030760A1 Use of prolactin for preventing and/or treating bird broodiness |
11/16/1995 | WO1995030759A1 Biologically active polypeptides inserted into an albumin |
11/16/1995 | WO1995030758A1 Recombinant hk2 polypeptide |
11/16/1995 | WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
11/16/1995 | WO1995030753A1 CHIMERIC DELTA-ENDOTOXIN EXPRESSION IN $i(PSEUDOMONAS FLUORESCENS) |
11/16/1995 | WO1995030752A1 IMPROVED BACILLUS THURINGIENSIS δ-ENDOTOXIN |
11/16/1995 | WO1995030751A1 Lanthionine-containing antimicrobial compound |
11/16/1995 | WO1995030750A2 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
11/16/1995 | WO1995030695A1 Interleukin-15 receptors |
11/16/1995 | WO1995030694A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
11/16/1995 | WO1995030693A1 Neurogenic differentiation (neurod) genes and proteins |
11/16/1995 | WO1995030691A1 New peptide active substance and production thereof |
11/16/1995 | WO1995030686A1 Production of biologically active recombinant neurotrophic protein |
11/16/1995 | WO1995030436A1 An adjuvant |
11/16/1995 | WO1995030435A2 Compositions and treatment for multiple sclerosis |
11/16/1995 | WO1995030433A1 A novel brain endothelial cell protein and methods for its use |
11/16/1995 | WO1995030432A1 Use of chondroitin sulphate proteoglycans for protection of neurons |
11/16/1995 | WO1995030430A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
11/16/1995 | WO1995030339A1 Cloning, expression, and uses of human lactoferrin |
11/16/1995 | WO1995030331A1 Compositions and methods of treating tumors |
11/16/1995 | WO1995022258A3 Isolation of lactoferrin from milk |
11/16/1995 | WO1995019371A3 Expression of surface layer proteins |
11/16/1995 | WO1995017521A3 Primers for the amplification of genes coding for the enterotoxin and the lecithinase of clostridium perfringens and their application to the detection and numeration of these bacteriae |
11/16/1995 | EP0690919A4 Crucifer acc synthase and uses thereof |
11/16/1995 | DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines |
11/16/1995 | CA2190027A1 A novel brain endothelial cell protein and methods for its use |
11/16/1995 | CA2189990A1 Compositions and treatment for multiple sclerosis |
11/16/1995 | CA2189774A1 Recombinant hk2 polypeptide |
11/16/1995 | CA2189582A1 Sv-40 derived dna constructs comprising exogenous dna sequences |
11/16/1995 | CA2189445A1 Use of prolactin for preventing and/or treating bird broodiness |
11/16/1995 | CA2189432A1 An adjuvant |
11/16/1995 | CA2188795A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
11/16/1995 | CA2188670A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
11/16/1995 | CA2188450A1 Neurogenic differentiation (neurod) genes and proteins |
11/16/1995 | CA2187534A1 Improved bacillus thuringiensis .delta.-endotoxin |
11/16/1995 | CA2186621A1 Lanthionine-containing antimicrobial compound |
11/15/1995 | EP0682257A1 Methods of detecting collagen degradation in vivo |
11/15/1995 | EP0682256A1 Methods of detecting collagen degradation in vivo |
11/15/1995 | EP0682115A1 Synthetic insecticidal crystal protein gene |
11/15/1995 | EP0682114A2 Expression of recombinant MPF-4, CPF-4, PF-4 and precursor compounds |
11/15/1995 | EP0682113A2 Polypeptide produced in an endothelial cell line and DNA encoding it |
11/15/1995 | EP0682112A1 Method for archiving expression, or to improve the level of expression of a gene |
11/15/1995 | EP0682111A1 Chimeric or transgenic animal and process for screening pharmaceutical products |
11/15/1995 | EP0682110A1 Recombinant DNA encoding PDGF A-chain polypeptides |
11/15/1995 | EP0682040A1 Humanized immunoglobulins and their production and use |
11/15/1995 | EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof |
11/15/1995 | EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method |
11/15/1995 | EP0681696A1 Non-denaturing potency assay for bovine somatotropin |
11/15/1995 | EP0681609A1 A process for the preparation of lipase |